TrialJournal of Alzheimer's disease : JAD2021

Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.

Jeffrey Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.